HomeIDIA • SWX
add
Idorsia Ltd
Previous close
CHF 3.54
Day range
CHF 3.40 - CHF 3.79
Year range
CHF 0.85 - CHF 4.85
Market cap
857.16M CHF
Avg Volume
1.53M
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Financials
Income Statement
Revenue
Net income
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 47.97M | -19.91% |
Operating expense | 62.84M | -5.26% |
Net income | -77.76M | 7.43% |
Net profit margin | -162.09 | -15.58% |
Earnings per share | — | — |
EBITDA | -47.78M | 12.89% |
Effective tax rate | -2.44% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.54M | -28.80% |
Total assets | 465.88M | -7.91% |
Total liabilities | 1.60B | -6.69% |
Total equity | -1.14B | — |
Shares outstanding | 250.74M | — |
Price to book | -0.78 | — |
Return on assets | -28.14% | — |
Return on capital | -99.94% | — |
Cash Flow
Net change in cash
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -77.76M | 7.43% |
Cash from operations | -43.33M | -293.80% |
Cash from investing | 4.83M | 755.84% |
Cash from financing | 63.27M | 141.59% |
Net change in cash | 24.73M | 67.78% |
Free cash flow | 18.34M | -40.02% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
938
